Form 4 for CV CapsoVision, Inc
Accepted 2025-07-07 00:00:00 ET · period of report 2025-07-03 · accession 0000950170-25-094309 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-07-07 | 2025-07-03 | CV | Tsai Chen Lung | Dir | C - Cnv Deriv | — | +91.4K | 115.5K | +381% | — |
| DMI | 2025-07-07 | 2025-07-03 | CV | Tsai Chen Lung | Dir | C - Cnv Deriv | $0.00 | -304.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-03 | C | A | 91,432 | — | 115,456 | I By trust. | — | — | (F1) Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F2) The securities are held by The Tsai Family Trust, for which the Reporting Person, together with his wife, are trustees. |
| 2 | Derivative | Series E Preferred Stock | 2025-07-03 | C | D | 86,956 | $0.00 | 0 | I By trust. | — · — to — | 26,112 Common Stock | (F2) The securities are held by The Tsai Family Trust, for which the Reporting Person, together with his wife, are trustees. (F1) Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 3 | Derivative | Series H Preferred Stock | 2025-07-03 | C | D | 90,534 | $0.00 | 0 | I By trust. | — · — to — | 27,187 Common Stock | (F2) The securities are held by The Tsai Family Trust, for which the Reporting Person, together with his wife, are trustees. (F1) Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 4 | Derivative | Series D-1 Preferred Stock | 2025-07-03 | C | D | 55,555 | $0.00 | 0 | I By trust. | — · — to — | 16,683 Common Stock | (F2) The securities are held by The Tsai Family Trust, for which the Reporting Person, together with his wife, are trustees. (F1) Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 5 | Derivative | Series B Preferred Stock | 2025-07-03 | C | D | 71,429 | $0.00 | 0 | I By trust. | — · — to — | 21,450 Common Stock | (F2) The securities are held by The Tsai Family Trust, for which the Reporting Person, together with his wife, are trustees. (F1) Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering. |